5 unchanged sentences
The Company paid quarterly cash dividends of $.09, $.10, $.12 and $.12 per share of common stock during the first, second, third and fourth quarters of 2021, respectively.
−Removed: The Company paid quarterly cash dividends of $0.09, $0.10, $0.12 and $0.12 per share of common stock during the first, second, third and fourth quarters of 2021, respectively.
+Added: The Company paid quarterly cash dividends of $.125 per share of common stock during each of the first, second, third and fourth quarters of 2022.
During the first quarter of 2023, the Company declared a dividend of $.25 per share of common stock to be paid on March 15, 2023 to stockholders of record as of March 1, 2023.
12 unchanged sentences
Total 9,494 $ 19.77 — $ 198,088,626
−Removed: (1) Includes 5,482 shares of common stock reacquired by the Company from holders of share-based awards to satisfy certain requirements associated with the vesting or exercise of the respective award.
+Added: (1) Represents shares of common stock reacquired by the Company from holders of share-based awards to satisfy certain requirements associated with the vesting or exercise of the respective award.
The shares were valued at the fair market value of the Company’s common stock on the vesting or exercise date of such awards, as set forth in the applicable plan document.
−Removed: (2) In February 2020, our Board of Directors authorized the repurchase of up to $100.0 million of our common stock through February 28, 2021, when and if market conditions warranted and to the extent legally permissible.
−Removed: In July 2020, our Board of Directors approved an extension of the February 2020 authorization by one year, through February 28, 2022.
−Removed: In May 2021, August 2021, and November 2021, our Board of Directors approved increases of $50.0 million, $70.0 million and $80.0 million, respectively, to the February 2020 authorization, resulting in an aggregate authorization of $300.0 million that expired on February 28, 2022.
−Removed: (3) In November 2021, the Company entered into an accelerated share repurchase agreement (the “2021 ASR Agreement”) with a third-party financial institution to repurchase common stock as part of the Company’s existing share repurchase program.
−Removed: Under the 2021 ASR Agreement, the Company paid the financial institution an initial
−Removed: purchase price of $125.0 million in cash and received an initial delivery of 4.9 million shares of common stock, representing an estimated 85% of the total shares expected to be delivered under the 2021 ASR Agreement.
−Removed: In February 2022, the Company completed the 2021 ASR Agreement and received an additional 0.7 million shares of common stock.
−Removed: The total number of shares of common stock ultimately purchased by the Company under the 2021 ASR Agreement was based on the average of the daily volume-weighted average prices of the common stock during the term of the 2021 ASR Agreement, less an agreed upon discount.
−Removed: In total, 5.6 million shares were delivered under the 2021 ASR Agreement at an average purchase price of $22.22 per share.
−Removed: With the completion of the 2021 ASR Agreement, the Company completed its $300.0 million February 2020 authorization.
−Removed: In February 2022, our Board of Directors authorized the repurchase of up to $100.0 million of our common stock through February 28, 2023, when and if market conditions warrant and to the extent legally permissible.
+Added: (2) In February 2022, our Board of Directors authorized the repurchase of up to $100.0 million of our common stock through February 28, 2023, when and if market conditions warranted and to the extent legally permissible (the “February 2022 Authorization”).
+Added: In April 2022, our Board of Directors approved an increase of $150.0 million to the February 2022 Authorization, resulting in an aggregate authorization of $250.0 million.
+Added: In January 2023, our Board of Directors authorized a repurchase program for up to $500.0 million of our common stock through February 28, 2027, when and if market conditions warrant and to the extent legally permissible (the “January 2023 Authorization”).
+Added: In connection with the January 2023 Authorization, the remaining portion of the February 2022 Authorization was canceled.
+Added: Subsequent to January 1, 2023 through February 21, 2023, the Company repurchased 0.6 million shares under the January 2023 Authorization with an aggregate purchase price of $12.9 million, excluding commissions.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.